The cultural collective of breast cancer advocacy and awareness activities, and an abundance of education efforts, information and news coverage have made breast cancer a familiar disease.
Thanks to the significant strides made in early detection, research, treatment and patient empowerment over the past 30 years, there is much progress to celebrate. Indeed, the prognosis of early stage breast cancer has transformed as survival rates have steadily increased.
But there is more work to be done, including increasing the focus on late stage breast cancer.
View some of Pfizer's current efforts below:
Breast Cancer: A Story Half Told
In 2014, Pfizer and leaders in the breast cancer community embarked on a first-of-its-kind research initiative that highlighted the public's lack of knowledge about metastatic breast cancer (MBC)—the most advanced form of the disease, for which there is no cure. Breast Cancer: A Story Half Told sheds further light on MBC from the perspective of women living with the disease.